ReviewOncoTargets and therapy2020

Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer.

Shiqiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.